You are viewing: GCC Countries Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The GCC Countries Long Read Sequencing Market was valued at $13.5 Million in 2024 and projected to reach to $46.6 Million by 2029, representing a compound annual growth rate of 28.1%. The GCC Countries long read sequencing market is poised for substantial growth through 2029, supported by significant healthcare sector investments and a regional shift toward precision medicine.

GCC Countries Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

GCC Countries Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 28.1%, reflecting strong regional adoption of advanced genomic technologies.
  • GCC Countries are increasingly investing in precision medicine infrastructure and genomic research capabilities, positioning the region as an emerging hub for long read sequencing applications across clinical diagnostics, oncology, and infectious disease research. GCC Countries' market growth is driven by rising healthcare expenditure, government support for biotechnology initiatives, and growing demand for accurate genetic analysis in personalized medicine.
  • The region's strategic focus on diversifying its economy beyond oil and gas has accelerated investment in healthcare innovation and genomic sequencing technologies.
  • By 2029, GCC Countries is expected to capture significant market share within the Middle East, supported by expanding laboratory infrastructure and increasing collaboration with international genomic research institutions..

Key Market Statistics

  • CAGR (2024-2029) 28.1% CAGR
  • Market Size, 2024 ~USD 13.5 Million
  • Forecast, 2029 ~USD 46.6 Million
  • Country GCC Countries

GCC Countries Long Read Sequencing Market Overview

Rapid Market Expansion :

GCC Countries' long read sequencing market is growing at 28.1% CAGR, expanding from $13.5 million in 2024 to $46.6 million by 2029, driven by increased healthcare investments and genomic research initiatives across the region.

Precision Medicine Infrastructure :

GCC nations are strategically investing in advanced genomic technologies and precision medicine capabilities, positioning themselves as regional hubs for personalized healthcare and genetic research applications.

Government Support & Funding :

Strong governmental backing for healthcare modernization and research initiatives in GCC Countries is accelerating adoption of long read sequencing technologies in clinical and research settings.

Regional Healthcare Advancement :

Increasing prevalence of genetic disorders and growing demand for advanced diagnostic solutions are propelling healthcare providers across GCC Countries to adopt cutting-edge sequencing technologies.

GCC Countries Long Read Sequencing Market Dynamics

  • Government initiatives promoting genomic research and diagnostic capabilities are creating favorable conditions for technology adoption.
  • Healthcare institutions across the UAE, Saudi Arabia, and other GCC nations are increasingly recognizing the clinical value of long read sequencing for rare disease diagnosis and cancer genomics. Market expansion will be further accelerated by rising healthcare expenditures, growing medical tourism, and the establishment of genomic research centers.
  • The region's focus on becoming a global healthcare innovation hub, combined with improving healthcare infrastructure and increasing awareness among clinicians, positions GCC Countries as a high-growth market for long read sequencing technologies through the forecast period..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • GCC Countries' long read sequencing market is projected to grow from $13.5M (2024) to $46.6M (2029) at a 28.1% CAGR.
    • GCC Countries is leveraging government healthcare investments and precision medicine initiatives to drive market expansion.
    • GCC Countries demonstrates strong demand for long read sequencing in oncology, infectious disease, and personalized medicine applications.
    • GCC Countries is emerging as a regional leader in genomic research infrastructure within the Middle East healthcare landscape.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    GCC Countries Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Healthcare Technology Providers : Sequencing equipment manufacturers and diagnostic solution vendors need GCC-specific market data to develop localized strategies, identify distribution partners, and capture growing demand for genomic technologies.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Middle Eastern healthcare and genomics require detailed market sizing, growth trajectories, and competitive dynamics specific to GCC Countries for informed capital allocation.
    • Healthcare Institutions & Hospitals : GCC-based medical centers and diagnostic laboratories need market insights to justify technology investments, benchmark against regional peers, and plan genomic service expansion.
    • Pharmaceutical & Biotech Companies : Drug developers and biotech firms require GCC market intelligence to identify precision medicine opportunities, understand patient populations, and develop region-specific clinical research programs.
    • Government & Policy Makers : Healthcare regulators and government agencies in GCC Countries need market data to inform precision medicine policies, research funding decisions, and healthcare infrastructure development initiatives.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations and growth projections specific to GCC Countries, enabling accurate business planning and investment decisions for the 2024-2029 period.
    • Competitive Landscape Analysis : Understand key players, market share dynamics, and competitive positioning within GCC Countries' long read sequencing sector to identify partnership and expansion opportunities.
    • Country-Specific Growth Drivers : Identify unique factors driving adoption across individual GCC nations, including regulatory environments, healthcare policies, and precision medicine initiatives shaping market demand.
    • Investment & Expansion Strategy : Leverage detailed market intelligence to develop targeted go-to-market strategies, identify high-potential segments, and prioritize resource allocation across GCC Countries.
    • Stakeholder Insights & Trends : Access comprehensive analysis of healthcare providers, research institutions, and government initiatives influencing long read sequencing adoption and technology implementation in the region.

    Frequently asked questions

    What is the current market size of long read sequencing in GCC Countries?

    The long read sequencing market in GCC Countries was valued at $13.5 million in 2024 and is expected to grow significantly through 2029.

    What is the projected growth rate for long read sequencing in GCC Countries?

    GCC Countries' long read sequencing market is projected to grow at a compound annual growth rate (CAGR) of 28.1% from 2024 to 2029.

    What will be the market size of long read sequencing in GCC Countries by 2029?

    The long read sequencing market in GCC Countries is forecasted to reach $46.6 million by 2029, representing a 245% increase from 2024 levels.

    What factors are driving growth in GCC Countries' long read sequencing market?

    GCC Countries' market growth is driven by increased healthcare spending, government biotechnology initiatives, rising demand for precision medicine, and expanding genomic research infrastructure.

    Which applications are most prominent for long read sequencing in GCC Countries?

    GCC Countries shows strong adoption of long read sequencing in clinical diagnostics, oncology research, infectious disease analysis, and personalized medicine applications.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status